_
Oct 21, 2014 |
_
US FDA Inspection
 
Eriochemís facilities has been inspected and accepted by US FDA
_

Eriochem received a GMP Inspection by US FDA from May 26th to June 3rd 2014 for an approved API (Vinorelbine Tartrate) and two new finished pharmaceutical products (Docetaxel and Melphalan)

In October 2014, as a result of this inspection, the CEO of the company received a letter informing that Eriochem’s facilities are considered acceptable by US FDA according to the inspection report.


US FDA Inspection'